HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SKB BIO-B

455.800

-1.800-0.39%

Volume:686.48K

Turnover:315.41M

Market Cap:106.29B

PE:-242.83

High:470.000

Open:458.000

Low:448.800

Close:457.600

52wk High:581.000

52wk Low:228.200

Shares:233.19M

HK Float Shares:162.77M

Volume Ratio:1.22

T/O Rate:0.42%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.877

ROE:-9.34%

ROA:-4.26%

PB:19.28

PE(LYR):-242.83

PS:45.59

Loading ...

Overview Company News Filings

SKB BIO-B (06990): Core ADC Sacituzumab Tirumotecan Delivers 0.45 HR in Final OS Analysis at 2026 ELCC

Bulletin Express

Breakthrough Survival Data for SKB BIO-B's Core ADC Therapy to be Presented at European Lung Cancer Conference

Kelun-Biotech reports final OptiTROP-Lung03 overall survival of 20 months for sac-TMT in EGFR-mutant NSCLC

Kelun-Biotech to present OptiTROP-Lung03 final OS analysis of sacituzumab tirumotecan at ELCC

Is New Long‑Acting Atopic Dermatitis Antibody IND Approval Altering The Investment Case For Kelun-Biotech (SEHK:6990)?

Simply Wall St.

Assessing Kelun-Biotech (SEHK:6990) Valuation After NMPA IND Approval For Long Acting Autoimmune Antibody

Simply Wall St.

Sichuan Kelun-Biotech Hires Associate For Promotional Services of Drug

MT Newswires Live

SKB BIO-B (06990) Signs 2026 Ancillary Market Management Services Framework Agreement with Kelun Jiaxun

BUZZ-Sichuan Kelun-Biotech jumps most in near 12 months on drug application

Clinical Trial Approval for TSLP Bispecific Antibody Boosts SKB BIO-B and HBM HOLDINGS-B Shares

Kelun-Biotech and Harbour Biomed Announce Nmpa Approval of Ind Application for Skb575/Hbm7575 for the Treatment of Atopic Dermatitis

THOMSON REUTERS

BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says NMPA Approves IND Application For SKB575/HBM7575

Sichuan Kelun-Biotech Secures Regulatory Approval to Begin Human Trials of Dermatology Drug

MT Newswires Live

Kelun-Biotech (06990.HK) Secures NMPA IND Green Light for Long-Acting Bispecific Antibody SKB575 Targeting Atopic Dermatitis

Bulletin Express

China NMPA approves Kelun-Biotech IND for SKB575 in atopic dermatitis

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Nmpa Approves Ind Application for Skb575/Hbm7575

THOMSON REUTERS

SKB BIO-B (06990) Announces Monthly Equity Movements for February 2026

Bulletin Express

A Look At Sichuan Kelun-Biotech Biopharmaceutical’s Valuation After The Crescent Biopharma Oncology Partnership

Simply Wall St.

BUZZ-Crescent Biopharma rises as global trial for new cancer drug starts

SKB BIO-B Falls 3.33% Against Market Trend, Weighed by Sector Weakness and Divergent Institutional Views

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/06990/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"SKB BIO-B","latestPrice":455.8,"timestamp":1774858100006,"preClose":457.6,"halted":0,"volume":686482,"delay":0,"changeRate":-0.003933566433566458,"floatShares":162769979,"shares":233185969,"eps":-1.8770456905440984,"marketStatus":"Not Yet Opened","change":-1.8,"latestTime":"03-30 16:08:20","open":458,"high":470,"low":448.8,"amount":315410820,"amplitude":0.046329,"askPrice":457.8,"askSize":1200,"bidPrice":455.8,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-1.8770456905440984,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774920600000},"marketStatusCode":0,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":457.6,"openAndCloseTimeList":[[1774834200000,1774843200000],[1774846800000,1774857600000]],"volumeRatio":1.2176969259416037,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":162769979,"roa":"-4.26%","roe":"-9.34%","lyrEps":-1.877046,"volumeRatio":1.2176969259416037,"shares":233185969,"dividePrice":0,"high":470,"amplitude":0.046329,"preClose":457.6,"low":448.8,"week52Low":228.2,"pbRate":"19.28","psRate":"45.59","week52High":581,"institutionHeld":0,"latestPrice":455.8,"committee":-0.714286,"eps":-1.8770456905440984,"divideRate":0,"volume":686482,"delay":0,"ttmEps":-1.8770456905440984,"open":458,"prevYearClose":392.2,"prevWeekClose":457.6,"prevMonthClose":387.4,"prevQuarterClose":392.2,"fiveDayClose":397.6,"twentyDayClose":375.2,"sixtyDayClose":399.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2026-03-23","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null},{"date":"2025-08-18","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post Market","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"Post Market","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-03-25","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3684,"buy":0.6316,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6316,"analysts":19,"updateTime":1774713600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2026-03-27","current":-242.828399,"percent":0.101493,"low":-351.800852,"twenty":-170.608939,"median":-124.791344,"eighty":-50.880899,"high":-21.029201,"avg":-126.848231,"sd":77.036146,"marketCap":106705913600},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200},{"date":"2025-04-25","current":-235.137362,"twenty":-160.624501,"median":-68.953584,"eighty":-45.131919,"marketCap":66771338400},{"date":"2025-05-02","current":-274.570331,"twenty":-161.195254,"median":-69.468586,"eighty":-45.197413,"marketCap":78134738400},{"date":"2025-05-09","current":-249.374354,"twenty":-161.514906,"median":-70.050704,"eighty":-45.202208,"marketCap":71462875059},{"date":"2025-05-16","current":-247.507619,"twenty":-162.87029,"median":-70.732965,"eighty":-45.217068,"marketCap":71507400214},{"date":"2025-05-23","current":-244.618313,"twenty":-163.824551,"median":-71.32983,"eighty":-45.58151,"marketCap":70884048033},{"date":"2025-05-30","current":-244.159494,"twenty":-165.025774,"median":-71.669987,"eighty":-45.601984,"marketCap":71062148656},{"date":"2025-06-06","current":-258.187076,"twenty":-166.004403,"median":-72.203519,"eighty":-46.006494,"marketCap":75336563613},{"date":"2025-06-13","current":-271.678883,"twenty":-167.701589,"median":-72.488214,"eighty":-46.133909,"marketCap":79304691313},{"date":"2025-06-20","current":-252.757485,"twenty":-168.349452,"median":-72.789206,"eighty":-46.315126,"marketCap":73636805593},{"date":"2025-06-27","current":-255.806605,"twenty":-169.647858,"median":-73.569836,"eighty":-46.457129,"marketCap":74733815733},{"date":"2025-07-04","current":-283.173205,"twenty":-171.495185,"median":-73.869687,"eighty":-46.685504,"marketCap":82732847998},{"date":"2025-07-11","current":-266.231967,"twenty":-173.142078,"median":-74.539848,"eighty":-46.749361,"marketCap":77704884860},{"date":"2025-07-18","current":-304.526119,"twenty":-187.755426,"median":-75.01675,"eighty":-46.798833,"marketCap":88812112519},{"date":"2025-07-25","current":-289.211949,"twenty":-196.095673,"median":-75.38559,"eighty":-46.877904,"marketCap":84652615741},{"date":"2025-08-01","current":-318.351212,"twenty":-209.071662,"median":-75.715906,"eighty":-46.908544,"marketCap":92605939250},{"date":"2025-08-08","current":-315.832709,"twenty":-214.487876,"median":-76.34536,"eighty":-47.149906,"marketCap":92103142937},{"date":"2025-08-15","current":-340.637946,"twenty":-221.73884,"median":-77.157567,"eighty":-47.354138,"marketCap":99188000086},{"date":"2025-08-22","current":-135.707825,"twenty":-221.73884,"median":-78.335478,"eighty":-47.421279,"marketCap":106638527281},{"date":"2025-08-29","current":-131.473703,"twenty":-217.466422,"median":-78.819337,"eighty":-47.438439,"marketCap":103804584421},{"date":"2025-09-05","current":-151.82862,"twenty":-215.82299,"median":-80.340969,"eighty":-47.449348,"marketCap":119756940196},{"date":"2025-09-12","current":-146.494298,"twenty":-214.791029,"median":-81.555855,"eighty":-47.474394,"marketCap":115757424063},{"date":"2025-09-19","current":-147.466634,"twenty":-214.487876,"median":-85.53437,"eighty":-47.73502,"marketCap":116443055400},{"date":"2025-09-26","current":-143.954691,"twenty":-214.295448,"median":-89.950081,"eighty":-47.938811,"marketCap":113375018127},{"date":"2025-10-03","current":-165.853778,"twenty":-213.463042,"median":-128.34687,"eighty":-48.070155,"marketCap":130933921593},{"date":"2025-10-10","current":-144.531455,"twenty":-212.219938,"median":-131.729362,"eighty":-48.217901,"marketCap":113934664453},{"date":"2025-10-17","current":-135.703716,"twenty":-210.108236,"median":-132.867642,"eighty":-48.374971,"marketCap":106892448189},{"date":"2025-10-24","current":-129.499037,"twenty":-207.014216,"median":-133.546653,"eighty":-48.434282,"marketCap":102042180034},{"date":"2025-10-31","current":-132.379263,"twenty":-204.550971,"median":-132.326202,"eighty":-48.483234,"marketCap":104467314112},{"date":"2025-11-07","current":-120.930715,"twenty":-203.710245,"median":-131.985022,"eighty":-48.610423,"marketCap":95373061321},{"date":"2025-11-14","current":-137.099974,"twenty":-201.138492,"median":-131.729362,"eighty":-48.622244,"marketCap":108431475585},{"date":"2025-11-21","current":-125.836792,"twenty":-194.360264,"median":-130.233026,"eighty":-48.651606,"marketCap":99477134375},{"date":"2025-11-28","current":-134.139839,"twenty":-194.090443,"median":-131.64896,"eighty":-48.675637,"marketCap":106426076251},{"date":"2025-12-05","current":-134.965867,"twenty":-192.863217,"median":-131.473703,"eighty":-48.751223,"marketCap":107265545740},{"date":"2025-12-12","current":-128.449432,"twenty":-188.527876,"median":-130.526276,"eighty":-48.814858,"marketCap":102275366003},{"date":"2025-12-19","current":-122.479247,"twenty":-187.446049,"median":-129.499037,"eighty":-48.911385,"marketCap":97751558204},{"date":"2025-12-24","current":-122.098928,"twenty":-187.290368,"median":-128.758533,"eighty":-48.913338,"marketCap":97751558204},{"date":"2026-01-02","current":-116.223952,"twenty":-179.729041,"median":-128.478737,"eighty":-49.104524,"marketCap":93414299181},{"date":"2026-01-09","current":-137.872108,"twenty":-173.799059,"median":-128.508043,"eighty":-49.251224,"marketCap":111089795631},{"date":"2026-01-16","current":-136.67551,"twenty":-173.152374,"median":-129.252083,"eighty":-49.296233,"marketCap":110483512112},{"date":"2026-01-23","current":-124.044288,"twenty":-172.874196,"median":-128.511935,"eighty":-49.590244,"marketCap":100176692282},{"date":"2026-01-30","current":-119.398299,"twenty":-172.654145,"median":-128.43808,"eighty":-50.08289,"marketCap":96865451522},{"date":"2026-02-06","current":-121.3325,"twenty":-172.20913,"median":-127.906249,"eighty":-50.304899,"marketCap":98684302080},{"date":"2026-02-13","current":-119.328264,"twenty":-171.604872,"median":-127.229577,"eighty":-50.349599,"marketCap":97611646623},{"date":"2026-02-20","current":-118.929435,"twenty":-171.385498,"median":-126.777731,"eighty":-50.372821,"marketCap":97145274685},{"date":"2026-02-27","current":-109.393801,"twenty":-170.608939,"median":-126.362178,"eighty":-50.420375,"marketCap":90336244390},{"date":"2026-03-06","current":-109.941252,"twenty":-169.952459,"median":-125.237252,"eighty":-50.5225,"marketCap":90056421227},{"date":"2026-03-13","current":-111.874188,"twenty":-169.826622,"median":-125.028422,"eighty":-50.583009,"marketCap":92061820561},{"date":"2026-03-20","current":-118.784792,"twenty":-169.647858,"median":-124.510593,"eighty":-50.752344,"marketCap":97378460654},{"date":"2026-03-27","current":-246.717525,"twenty":-170.608939,"median":-124.791344,"eighty":-50.880899,"marketCap":106705913600}],"updateTime":1774906130353},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1171768127","title":"SKB BIO-B (06990): Core ADC Sacituzumab Tirumotecan Delivers 0.45 HR in Final OS Analysis at 2026 ELCC","url":"https://stock-news.laohu8.com/highlight/detail?id=1171768127","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171768127?lang=en_us&edition=fundamental","pubTime":"2026-03-18 23:03","pubTimestamp":1773846222,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO-B, 06990) released final overall survival (OS) data for its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"gpt_icon":0},{"id":"1104074741","title":"Breakthrough Survival Data for SKB BIO-B's Core ADC Therapy to be Presented at European Lung Cancer Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1104074741","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104074741?lang=en_us&edition=fundamental","pubTime":"2026-03-18 22:52","pubTimestamp":1773845546,"startTime":"0","endTime":"0","summary":"SKB BIO-B (06990) announced that the final overall survival analysis results from the pivotal clinical trial (OptiTROP-Lung03) of its TROP2-targeting antibody-drug conjugate (ADC), sacituzumab...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2620252791","title":"Kelun-Biotech reports final OptiTROP-Lung03 overall survival of 20 months for sac-TMT in EGFR-mutant NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2620252791","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620252791?lang=en_us&edition=fundamental","pubTime":"2026-03-18 22:42","pubTimestamp":1773844945,"startTime":"0","endTime":"0","summary":"Kelun-Biotech said final overall survival results from the OptiTROP-Lung03 trial of sacituzumab tirumotecan  in previously treated EGFR-mutant non-small cell lung cancer will be presented at the 2026 European Lung Cancer Congress, with updated progression-free survival data also scheduled. The company noted that earlier OptiTROP-Lung03 results were presented at the 2025 ASCO Annual Meeting, reporting a hazard ratio of 0.30 for blinded independent central review-assessed progression-free survival and 0.49 for overall survival versus docetaxel. In the final analysis dataset, 41.3% of patients in the docetaxel arm crossed over to receive sac-TMT after progression. Using a rank-preserving structural failure time model to adjust for crossover, median overall survival was 20 months with sac-TMT versus 11.2 months with docetaxel . Investigator-assessed median progression-free survival was 7.9 months for sac-TMT versus 2.8 months for docetaxel .","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLbBFJPx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","LU2148510915.USD","BK0060","002422","LU1979443071.USD","06990","LU1064131003.USD","BK1161","LU1934453819.USD","BK0239","LU1064130708.USD"],"gpt_icon":0},{"id":"2620252597","title":"Kelun-Biotech to present OptiTROP-Lung03 final OS analysis of sacituzumab tirumotecan at ELCC","url":"https://stock-news.laohu8.com/highlight/detail?id=2620252597","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620252597?lang=en_us&edition=fundamental","pubTime":"2026-03-18 22:28","pubTimestamp":1773844122,"startTime":"0","endTime":"0","summary":"Kelun-Biotech will attend the European Lung Cancer Congress  in Copenhagen, Denmark, held March 25-28, 2026. The company said the final overall survival analysis from the OptiTROP-Lung03 study of sacituzumab tirumotecan has been selected as a Late-Breaking Abstract  and will be presented in a mini oral session. Professor Yunpeng Yang is scheduled to present the findings.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL7GXm7Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LU1064131003.USD","002422","BK1161","LU2148510915.USD","LU0196878994.USD","BK0060","LU1934453819.USD","LU1979443071.USD","LU1064130708.USD","06990"],"gpt_icon":0},{"id":"2619889904","title":"Is New Long‑Acting Atopic Dermatitis Antibody IND Approval Altering The Investment Case For Kelun-Biotech (SEHK:6990)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2619889904","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619889904?lang=en_us&edition=fundamental","pubTime":"2026-03-15 23:15","pubTimestamp":1773587737,"startTime":"0","endTime":"0","summary":"On 9 March 2026, Kelun-Biotech and Harbour BioMed announced that China’s NMPA approved the IND application for SKB575/HBM7575, a long-acting bispecific antibody for atopic dermatitis with a dual TSLP-based mechanism and extended half-life enabling subcutaneous dosing.\nThis IND approval highlights Kelun-Biotech’s growing capabilities in innovative biologics and positions SKB575/HBM7575 as a potentially differentiated long-interval therapy candidate in atopic dermatitis.\nWe will now examine...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/is-new-longacting-atopic-dermatitis-antibody-ind-approval-al","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/is-new-longacting-atopic-dermatitis-antibody-ind-approval-al","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["06990","BK4585","BK4588","IND","BK4581","LU0196878994.USD","XBI","BK1161"],"gpt_icon":0},{"id":"2619214665","title":"Assessing Kelun-Biotech (SEHK:6990) Valuation After NMPA IND Approval For Long Acting Autoimmune Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2619214665","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619214665?lang=en_us&edition=fundamental","pubTime":"2026-03-14 04:23","pubTimestamp":1773433411,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) just cleared a key hurdle in autoimmune drug development, with China’s NMPA approving the IND for SKB575/HBM7575, a long acting bispecific antibody for atopic dermatitis.\nSee our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical.\nThe IND approval landed as Sichuan Kelun-Biotech Biopharmaceutical’s 1 day share price return of 1.75% and 7 day share price return of 2.23% contrast with a 30 day share price return of about a 10%...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/assessing-kelun-biotech-sehk6990-valuation-after-nmpa-ind-ap","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/assessing-kelun-biotech-sehk6990-valuation-after-nmpa-ind-ap","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4588","06990","LU0196878994.USD","DCF","BK1161","IND","XBI","BK4581"],"gpt_icon":0},{"id":"2618687994","title":"Sichuan Kelun-Biotech Hires Associate For Promotional Services of Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2618687994","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618687994?lang=en_us&edition=fundamental","pubTime":"2026-03-11 11:11","pubTimestamp":1773198707,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical  hired its associate Kelun Jiaxun for auxiliary promotional services of its drug SKB264, according to a Hong Kong bourse filing Tuesday.Shares of the drug maker fell nearly 2% in morning trade Wednesday.The framework will last till the end of 2028, with annual caps of 20 million yuan in service fees payable by Sichuan Kelun-Biotech to Kelun Jiaxun.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","06990","BK4581","XBI","LU0196878994.USD","BK4585","BK4588"],"gpt_icon":0},{"id":"1100392981","title":"SKB BIO-B (06990) Signs 2026 Ancillary Market Management Services Framework Agreement with Kelun Jiaxun","url":"https://stock-news.laohu8.com/highlight/detail?id=1100392981","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100392981?lang=en_us&edition=fundamental","pubTime":"2026-03-10 22:47","pubTimestamp":1773154035,"startTime":"0","endTime":"0","summary":"SKB BIO-B (06990) announced that on March 10, 2026, the company entered into a 2026 Ancillary Market Management Services Framework Agreement with Kelun Jiaxun. Under this agreement, the Kelun Jiaxun...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2618602162","title":"BUZZ-Sichuan Kelun-Biotech jumps most in near 12 months on drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2618602162","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618602162?lang=en_us&edition=fundamental","pubTime":"2026-03-10 10:45","pubTimestamp":1773110720,"startTime":"0","endTime":"0","summary":"BUZZ-Sichuan Kelun-Biotech jumps most in near 12 months on drug application** Shares of Sichuan Kelun-Biotech Biopharmaceutical 6990.HK jump 10% to HK$418, on course for the biggest one-day pct gain since March 27, 2025 ** Stock hit the highest level since February 23** The China-based oncology and immunology drug producer said the National Medical Products Administration  has approved the Investigational New Drug  application for SKB575/HBM7575, a long-acting bispecific antibody for the treatment of atopic dermatitis ** SKB575/HBM7575 is co-developed by the company and HBM Holdings 2142.HK ** Shares of HBM climb 4.8% to HK$12.06, on track for the biggest one-day pct rise since January 8** YTD, HBM shares down 2%, while Sichuan Kelun-Biotech stock up 5.4%, Hang Seng Biotech Index .HSBIO up 3.7%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nL1N3ZY02L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142","LU2148510915.USD","BK1574","06990","LU1934453819.USD","BK1583","LU1064130708.USD","BK1161","002422","LU1979443071.USD","BK0060","BK0239","LU1064131003.USD","LU0196878994.USD"],"gpt_icon":0},{"id":"1148853674","title":"Clinical Trial Approval for TSLP Bispecific Antibody Boosts SKB BIO-B and HBM HOLDINGS-B Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1148853674","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148853674?lang=en_us&edition=fundamental","pubTime":"2026-03-10 10:18","pubTimestamp":1773109105,"startTime":"0","endTime":"0","summary":"Shares of SKB BIO-B (06990) and HBM HOLDINGS-B (02142) rose in morning trading. At the time of writing, SKB BIO-B was up 8.95%, trading at HK$414, while HBM HOLDINGS-B advanced 4.26% to HK$12. The...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","VXUS","06990","BK4588","02142","BK1574","BK4585","BK1583","BK1161"],"gpt_icon":0},{"id":"2618864704","title":"Kelun-Biotech and Harbour Biomed Announce Nmpa Approval of Ind Application for Skb575/Hbm7575 for the Treatment of Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2618864704","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618864704?lang=en_us&edition=fundamental","pubTime":"2026-03-09 18:48","pubTimestamp":1773053297,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nTUA5Z2MXJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2618647372","title":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says NMPA Approves IND Application For SKB575/HBM7575","url":"https://stock-news.laohu8.com/highlight/detail?id=2618647372","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618647372?lang=en_us&edition=fundamental","pubTime":"2026-03-09 18:27","pubTimestamp":1773052075,"startTime":"0","endTime":"0","summary":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says NMPA Approves IND Application For SKB575/HBM7575March 9 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd 6990.HK:NMPA APPROVES IND APPLICATION FOR SKB575/HBM7575Further company coverage: 6990.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nFWN3ZU1LJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2618114644","title":"Sichuan Kelun-Biotech Secures Regulatory Approval to Begin Human Trials of Dermatology Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2618114644","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618114644?lang=en_us&edition=fundamental","pubTime":"2026-03-09 17:42","pubTimestamp":1773049366,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical (HKG:6990) to begin studying its SKB575 drug in human trials, according to a Hong Kong bourse filing Monday.The firm plans to study the drug as a treatment of atopic dermatitis.SKB575 is also known as HBM7575.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"1167009924","title":"Kelun-Biotech (06990.HK) Secures NMPA IND Green Light for Long-Acting Bispecific Antibody SKB575 Targeting Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=1167009924","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167009924?lang=en_us&edition=fundamental","pubTime":"2026-03-09 16:43","pubTimestamp":1773045821,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (Kelun-Biotech, 06990.HK) announced that China’s National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND)...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"gpt_icon":0},{"id":"2618646914","title":"China NMPA approves Kelun-Biotech IND for SKB575 in atopic dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2618646914","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618646914?lang=en_us&edition=fundamental","pubTime":"2026-03-09 16:32","pubTimestamp":1773045176,"startTime":"0","endTime":"0","summary":"China’s National Medical Products Administration approved Kelun-Biotech’s investigational new drug application for SKB575/HBM7575 for atopic dermatitis. Harbour BioMed co-developed the long-acting bispecific antibody with Kelun-Biotech.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDL2L2NXH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","LU1064131003.USD","LU1934453819.USD","BK1583","BK1161","BK0060","LU0196878994.USD","LU1064130708.USD","002422","02142","BK1574","LU1979443071.USD","BK0239","LU2148510915.USD"],"gpt_icon":0},{"id":"2618646965","title":"Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Nmpa Approves Ind Application for Skb575/Hbm7575","url":"https://stock-news.laohu8.com/highlight/detail?id=2618646965","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618646965?lang=en_us&edition=fundamental","pubTime":"2026-03-09 16:32","pubTimestamp":1773045150,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nFWN3ZU1LJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"1176736673","title":"SKB BIO-B (06990) Announces Monthly Equity Movements for February 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1176736673","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176736673?lang=en_us&edition=fundamental","pubTime":"2026-03-04 17:19","pubTimestamp":1772615984,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO-B, stock code 06990) released a monthly return for the period ended 28 February 2026. The total authorized share capital remained at RMB...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"gpt_icon":0},{"id":"2616848837","title":"A Look At Sichuan Kelun-Biotech Biopharmaceutical’s Valuation After The Crescent Biopharma Oncology Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2616848837","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616848837?lang=en_us&edition=fundamental","pubTime":"2026-02-28 22:31","pubTimestamp":1772289080,"startTime":"0","endTime":"0","summary":"Why the Crescent Biopharma partnership matters for Sichuan Kelun-Biotech Biopharmaceutical\nThe new collaboration between Crescent Biopharma and Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) on next generation oncology drugs, including joint clinical trials, is drawing fresh attention from investors to Kelun-Biotech's pipeline and funding position.\nSee our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical.\nAt the latest share price of HK$387.4, Sichuan Kelun-Biotech...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/a-look-at-sichuan-kelun-biotech-biopharmaceuticals-valuation","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/a-look-at-sichuan-kelun-biotech-biopharmaceuticals-valuation","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LABU","DCF","BK1161","BK4588","06990","BK4585","LU0196878994.USD"],"gpt_icon":0},{"id":"2612440859","title":"BUZZ-Crescent Biopharma rises as global trial for new cancer drug starts","url":"https://stock-news.laohu8.com/highlight/detail?id=2612440859","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612440859?lang=en_us&edition=fundamental","pubTime":"2026-02-19 01:00","pubTimestamp":1771434027,"startTime":"0","endTime":"0","summary":"BUZZ-Crescent Biopharma rises as global trial for new cancer drug starts** Shares of drugmaker Crescent Biopharma CBIO.O rise 4% to $9.68  ** Co says it has begun a global earlystage trial of CR001 for advanced solid tumors** CR001 is an experimental cancer drug designed to help the immune system attack tumors and block blood supply, CBIO says** Co says study will test safety and how the drug moves and acts in the body before checking for early signs of tumor shrinkage** Trial to enroll up to 290 patients across the U.S., Europe and Asia Pacific; initial data expected in early 2027, CBIO says** Co says it has granted China-based cancerdrug developer Sichuan Kelun-Biotech exclusive rights to develop and sell the drug in Greater China** Shares down ~52% in 2025  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nL4N3ZE19W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","BK0239","LU0196878994.USD","LU1934453819.USD","BK0060","LU1064131003.USD","LU2148510915.USD","BK4139","LU1979443071.USD","002422","CBIO","LU1064130708.USD"],"gpt_icon":0},{"id":"1185804801","title":"SKB BIO-B Falls 3.33% Against Market Trend, Weighed by Sector Weakness and Divergent Institutional Views","url":"https://stock-news.laohu8.com/highlight/detail?id=1185804801","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185804801?lang=en_us&edition=fundamental","pubTime":"2026-02-12 20:22","pubTimestamp":1770898930,"startTime":"0","endTime":"0","summary":"On February 12, 2026, SKB BIO-B (06990.HK) declined by 3.33% against the broader market trend, closing at HKD 423.40 with a turnover of HKD 208 million. The drop was primarily influenced by the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":140,"code":"91000000","status":"200"}]}}